Sherlock Biosciences, Inc.
Medical device company · Brighton, Massachusetts, United States
Sherlock Biosciences, Inc. is a medical device company headquartered in Brighton, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $298,948 in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $80 million sold in a notice filed in 2022.
Sherlock Biosciences at a glance
What does Sherlock Biosciences do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $298,948 in total (2024). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $80 million sold (2022).
Frequently asked questions about Sherlock Biosciences
Where is Sherlock Biosciences headquartered?
Sherlock Biosciences, Inc. is headquartered in Brighton, Massachusetts, United States.
What does Sherlock Biosciences do?
Sherlock Biosciences, Inc. is a medical device company.
When was Sherlock Biosciences founded?
The earliest incorporation on record for Sherlock Biosciences, Inc. is in 2018, according to public company registers.
Similar companies
- Platform Innovations Inc.Brighton, Colorado, United States
- GLAUKOS CorpAliso Viejo, California, United States
- Mobia Medical, Inc.Austin, Texas, United States
- Pulse Biosciences, Inc.Hayward, California, United States
- Artivion, Inc.Kennesaw, Georgia, United States
- PAVmed Inc.New York City, New York, United States
- Medtronic IncMinneapolis, Minnesota, United States
- Sintx Technologies, Inc.Salt Lake City, Utah, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences